Treatment changes in a cohort of people with apparently drug-resistant epilepsy: An extended follow-up

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 8, 2012, Pages 810-813

  Neligan, Aidan ^a   Bell, Gail S ^a   Elsayed, Muaz ^a   Sander, Josemir W ^a,b   Shorvon, Simon D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; COHORT ANALYSIS; DISEASE CONTROL; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELAPSE; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84863981922     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-302085     Document Type: Article

References (16)

1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-19.
2. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-77.
3. Gomez-Alonso J, Gil-Nagel A. A graded system to categorize drug-resistant epilepsy. Epilepsia 2010;51:2360-1.
4. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007;62:375-81.
5. Callaghan BC, Anand K, Hesdorffer D, et al. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007;62:382-9.
6. Choi H, Heiman G, Pandis D, et al. Seizure remission and relapse in adults with intractable epilepsy: a cohort study. Epilepsia 2008;49:1440-5.
7. Berg AT, Levy SR, Testa FM, et al. Remission of epilepsy after two drug failures in children: a prospective study. Ann Neurol 2009;65:510-19.
8. Callaghan B, Schlesinger M, Rodemer W, et al. Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia 2011;52:619-26.
9. Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 2008;70:54-65.
10. Choi H, Heiman GA, Clary HM, et al. Seizure remission in adults with long-standing intractable epilepsy: an extended follow-up. Epilepsy Res 2011;93:115-19.
11. Neligan A, Bell GS, Sander JW, et al. How refractory is refractory epilepsy? Patterns of relapse and remission in people with refractory epilepsy. Epilepsy Res 2011;96:225-30.
12. Lhatoo SD, Solomon JK, McEvoy AW, et al. A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia 2003;44:673-6.
13. Chaves J, Sander JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):133-9.
14. Thomas P, Valton L, Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006;129:1281-92.
15. Neligan A. Drug induced seizures. In: Shorvon SD, Andermann F, Guerrini R, eds. The Causes of Epilepsy, Common and Uncommon Causes in Adults and Children. Cambridge: Cambridge University Press, 2011:664-74.
16. Somerville ER. Seizure aggravation by antiepileptic drugs. Curr Treat Options Neurol 2006;8:289-96.